Rafferty Asset Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.79M Sell
72,607
-25,934
-26% -$1.65M 0.02% 382
2025
Q4
$6.26M Sell
98,541
-5,567
-5% -$346K 0.02% 359
2025
Q3
$5.72M Sell
104,108
-67,473
-39% -$2.78M 0.02% 396
2025
Q2
$5.67M Buy
171,581
+22,074
+15% +$768K 0.02% 372
2025
Q1
$6.01M Sell
149,507
-18,428
-11% -$847K 0.03% 330
2024
Q4
$7.9M Sell
167,935
-48,891
-23% -$2.54M 0.03% 324
2024
Q3
$11.4M Sell
216,826
-48,243
-18% -$2.69M 0.04% 265
2024
Q2
$14.4M Buy
265,069
+125,592
+90% +$7.58M 0.05% 217
2024
Q1
$9.78M Sell
139,477
-123,798
-47% -$9.57M 0.04% 273
2023
Q4
$22M Buy
263,275
+16,353
+7% +$592K 0.09% 132
2023
Q3
$7.27M Buy
246,922
+22,498
+10% +$749K 0.04% 307
2023
Q2
$7.32M Buy
224,424
+33,270
+17% +$1.23M 0.04% 324
2023
Q1
$6.73M Sell
191,154
-34,223
-15% -$1.4M 0.05% 305
2022
Q4
$10.3M Buy
225,377
+98,277
+77% +$4.23M 0.09% 175
2022
Q3
$6.16M Buy
127,100
+30,443
+31% +$1.47M 0.07% 278
2022
Q2
$3.8M Sell
96,657
-45,945
-32% -$1.85M 0.04% 342
2022
Q1
$5.25M Sell
142,602
-3,466
-2% -$123K 0.03% 381
2021
Q4
$6.66M Buy
146,068
+40,511
+38% +$1.56M 0.04% 273
2021
Q3
$3.77M Sell
105,557
-18,424
-15% -$542K 0.03% 382
2021
Q2
$2.45M Sell
123,981
-22,020
-15% -$517K 0.02% 615
2021
Q1
$3.4M Buy
146,001
+106,276
+268% +$2.27M 0.02% 407
2020
Q4
$825K Sell
39,725
-31,392
-44% -$574K 0.01% 562
2020
Q3
$1.54M Buy
71,117
+49,344
+227% +$1.15M 0.02% 487
2020
Q2
$513K Buy
+21,773
New +$408K 0.01% 703
2020
Q1
Sell
-47,996
Closed -$509K 648
2019
Q4
$509K Sell
47,996
-24,648
-34% -$253K 0.01% 684
2019
Q3
$827K Sell
72,644
-787
-1% -$9.88K 0.01% 579
2019
Q2
$826K Buy
73,431
+24,680
+51% +$238K 0.01% 596
2019
Q1
$394K Buy
+48,751
New +$358K 0.01% 701

Other funds holding CYTK